business
Metsera Dives After The Pfizer-Novo Buyout Battle Ends - Investor's Business Daily
Metsera Stock Plummets After Pfizer Wins Buyout Battle In a significant development in the world of pharmaceuticals, Metsera (MTSR) stock suffered a substantial decline on Monday following an announcement that Pfizer (PFE) would acquire the company for up to $10 billion. The news marked the end of a high-stakes buyout